Drug Trial Radar · NCT04970654
A Research Study in Chinese Children With a Low Level of Hormone to Grow. Treatment is Somapacitan Once a Week Compared to Norditropin® Once a Day.
Last checked: Nov 20, 2026Latest source record: Jan 6, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
110
Actual
Start
Jul 22, 2021
Primary completion
Nov 17, 2023
Study completion Dec 18, 2023
Sponsor
- Lead sponsor
- Novo Nordisk A/SNovo Nordisk (NVO)
- Sponsor type
- Industry
- First posted
- Jul 21, 2021
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The study compares two medicines for children with a low level of hormone to grow: somapacitan (a new medicine) given once a week and Norditropin® (a medicine doctors can already prescribe) given once a day. Researchers will test somapacitan to see how well it works, compared to the standard treatment with Norditropin®. The participants will either get Norditropin® once every day or somapacitan once every week - which treatment the participant gets is decided by chance. The participant and the study doctor will know which treatment the participant gets. The study includes a 52 week treatment period and a minimum of 30 days follow up period.
Conditions
- Growth Hormone Deficiency in Children
Interventions
somapacitanDrug
Somapacitan (0.16 mg/kg/week) will be administered subcutaneously (s.c.; under the skin) once weekly by PDS290 pen-injector. Somapacitan can be injected any time during the once weekly dosing day. The dose will be calculated based on the subject's current body weight.
Norditropin®Drug
Norditropin® (0.034 mg/kg/day) will be administered s.c. once daily by FlexPro® pen-injector. Norditropin® should be injected daily in the evening. The dose will be calculated based on the subject's current body weight.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Height VelocityTime frame: Baseline (Week 0); Week 52
Locations
32 sites in 1 country. Site status is shown where the registry gives one.
Wuhan Children Hospital-Endocrine Genetics and Metabolism
Wuhan, China
The Second Hospital of Anhui Medical University
Hefei, Anhui, China
Capital Center for Children's Health, Capital Medical University-Endocrinology
Beijing, Beijing Municipality, China
Beijing Children's Hospital, Capital Medical University
Beijing, Beijing Municipality, China
The First Affiliated Hospital of Xiamen University-Pediatric
Xiamen, Fujian, China
The First Affiliated Hospital, Sun Yat-sen University
Guangzhou, Guangdong, China
The Third Affiliated Hospital, Sun Yat-Sen University-Pediatric
Guangzhou, Guangdong, China
Henan Children's Hospital Zhengzhou Children's Hospital-Endocrine Genetics and Metabolism
Zhengzhou, Henan, China
Henan Children's Hospital
Zhengzhou, Henan, China
Tongji Hospital, Tongji Medical College of HUST-Pediatric
Wuhan, Hubei, China
Hunan Children's Hospital-Child Health Center
Changsha, Hunan, China
Hunan Children's Hospital
Changsha, Hunan, China
The Second Xiangya Hospital of Central South University
Changsha, Hunan, China
The First Affiliated Hospital of Shaoyang University-Pediatric
Shaoyang, Hunan, China
Jiangxi Provincial Children's Hospital-Endocrine Genetics and Metabolism
Nanchang, Jiangsu, China
Children's Hospital of Soochow University-Endocrine Genetics and Metabolism
Suzhou, Jiangsu, China
Children's Hospital of Soochow University
Suzhou, Jiangsu, China
Wuxi Children's Hospital-Pediatric Endocrinology
Wuxi, Jiangsu, China
Wuxi Children's Hospital
Wuxi, Jiangsu, China
The First Hospital of Jiaxing-Pediatric
Jiaxing, Jiangxi, China
The First Hospital of Jiaxing
Jiaxing, Jiangxi, China
Pingxiang Maternal and Child Health Care Hospital-Child Health Care
Pingxiang, Jiangxi, China
Pingxiang Maternal and Child Health Care Hospital
Pingxiang, Jiangxi, China
The First Bethune Hospital of Jilin University-Pediatric
Changchun, Jilin, China
The First Bethune hospital of Jilin University-Endocrinology
Changchun, Julin, China
Shandong Provincial Hospital-Pediatric
Jinan, Shandong, China
Women & Children's Health Care Hospital of Linyi-Endocrine Genetics and Metabolism
Linyi, Shandong, China
Qingdao Women and Children's Hospital-Pediatric Endocrinology&Metabolism
Qingdao, Shandong, China
Qingdao Women and Children's Hospital
Qingdao, Shandong, China
Shanghai Children's Hospital
Shanghai, Shanghai Municipality, China
Chengdu Women's and Children's Central Hospital
Chengdu, Sichuan, China
Children's Hospital, Zhejiang University School of Medicine
Hangzhou, Zhejiang, China
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.